STAT+: House panel advances bill to extend Medicare’s telehealth flexibilities, setting up December talks
A House committee on Wednesday advanced legislation that would extend Medicare telehealth flexibilities and a…
Category: Medicare
STAT+: What pharma companies and insurers think about Medicare’s plan to cover digital treatments
In July, Medicare proposed to start paying for some mental health apps, in a move…
STAT+: What Medicare Advantage enrollment could look like for next year
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Insurers went all-in on Medicare Advantage. Now, some are scaling back
For years, health insurers battled to gain market share in the lucrative privatized Medicare program….
STAT+: Humana cutting Medicare Advantage plans that cover 10% of members
Roughly 10% of people enrolled in Humana’s private Medicare plans will have to find new…
Opinion: Health care price regulation is undemocratic
The Biden administration recently announced that it will use taxpayer dollars to “stabilize” Medicare Part…
Opinion: Medicare’s new transitional coverage of emerging technologies program doesn’t go far enough
Included in the original law that established Medicare in 1965 was a short but consequential…
STAT+: Centene eliminates brokers’ commissions for Medicare drug plans
Health insurer Centene will not pay any commissions to brokers and agents who help people…
Patient volumes have stormed back into hospitals
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
5 health issues to watch for at the Democratic National Convention
WASHINGTON — Democrats have set the stage for a convention this week packed with boasts…
Opinion: STAT+: What the newly released Medicare prices for 10 drugs do and don’t tell us
For many of us, Thursday was Health-Policy-Wonk Festivus. The Centers for Medicare & Medicaid Services…
Harris pledges to scrap billions in medical debt with new presidential platform
WASHINGTON — Vice President Harris says she wants to cancel billions of dollars in medical…
STAT+: What do Biden’s drug price comparisons reveal? Not much
WASHINGTON — The White House is touting just how much its new Medicare negotiation process…
Listen: Drug pricing drops & psychedelics under fire
Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and…
Medicare drug price negotiation didn’t benefit Biden — but it may help Harris
WASHINGTON — When Vice President Kamala Harris takes the stage at the Democratic National Convention…
STAT+: Medicare announces drug prices for historic first round of negotiations
WASHINGTON — The day drug makers dreaded has finally arrived. Medicare officials on Thursday unveiled…
Arthritis patients resort to an inconvenient Medicare workaround to avoid pricey drugs
As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions…
The politics of mifepristone in the 2024 election
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Medicare paid substantially more for J&J’s Stelara when it was covered under Part D than under Part B
A popular biologic medicine used to combat autoimmune diseases cost Medicare and its beneficiaries considerably…
STAT+: Judge rules against Chamber of Commerce in Medicare drug negotiation lawsuit
WASHINGTON — A federal judge on Thursday tossed out a U.S. Chamber of Commerce lawsuit…
STAT+: Big Health gets FDA nod for its digital therapy for insomnia
Digital Therapeutics developer Big Health this week received Food and Drug Administration clearance for SleepioRx,…
STAT+: Medicare finalizes reimbursement rule for breakthrough medical devices
The Centers for Medicare and Medicaid Services has finalized its rule easing reimbursement for medical…
STAT+: CVS removes top Aetna leader as higher medical costs eat further into profits
CVS Health continued to pay out more than it expected for the medical claims of…
STAT+: How UnitedHealth turned a questionable artery-screening program into a gold mine
The nation’s largest health care company pressed thousands of its clinicians to use a thinly…
STAT+: Medicare scrambles to keep prescription drug plan premiums stable ahead of elections
WASHINGTON — Medicare officials are offering private insurers big subsidies to keep premiums for prescription-drug…
STAT+: How to tell if Biden drove a hard bargain on drug prices
WASHINGTON — The deadline for announcing how much Medicare lowered drug prices in the first…
STAT+: Disruptions loom for telehealth providers and patients as Congress inches closer to deadline
Around November, Kivo Health, a telehealth provider of pulmonary rehabilitation services, will need to start…
Opinion: Without federal oversight, nursing homes will put profit ahead of care
About 5% of Americans require skilled care at some point as they age. The horrific…
Six questions about Medicare’s proposed plan to cover digital therapeutics
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
STAT+: How UnitedHealth harnesses its physician empire to squeeze profits out of patients
UnitedHealth Group started out as a small, Minnesota health insurance company and has since morphed…
Watch: How insurers use doctors to profit off medical codes
Insurers like UnitedHealth are profiting off of the Medicare Advantage system, and it’s causing problems…
Opinion: To get a fair deal on Wegovy, buying Novo Nordisk might not be Medicare’s worst option
Medicare and Medicaid are facing a familiar quandary: how to provide coverage for new weight…
Harris health care agenda swiftly hailed by progressives and reproductive rights groups
WASHINGTON — President Biden’s announcement Sunday that he would be dropping out of the presidential…
Kamala Harris, endorsed by Biden to replace him, is left of the president on health care
WASHINGTON — President Biden is ending his bid for a second term in office and…
Opinion: Readers respond to essays on philanthropy and nursing schools, opioid overdoses, and more
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the…
STAT+: Here come Medicare’s first negotiated drug prices
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Medicare pay proposals are good news for health tech, bad news for docs
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: The effort to reform physician pay is set to pit primary care docs against highly paid specialists
WASHINGTON — There’s been a long lull in fighting between primary care and specialty doctors…
Opinion: Medicare drug pricing rules will delay access to promising therapies
Medicare’s new guidelines cover how it will conduct the drug price negotiations authorized by the…
STAT+: Medicare proposes to cover some digital therapies in a breakthrough for health tech firms
In what could prove to be a lifeline for a new crop of health tech…
Trump’s 2024 platform abandons calls to cut Medicare, broadly restrict abortion
WASHINGTON — Former President Trump says he “will not cut one penny” from Medicare and…
STAT+: Pulling back the curtain on psychiatric hospital joint ventures
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Judge rules against Boehringer Ingelheim in pharma’s latest legal loss on Medicare negotiation
WASHINGTON — A federal judge ruled against Boehringer Ingelheim’s challenge to the new Medicare drug…
Making sense of the debate’s health care debate
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Opinion: Medicare should wait on approving coverage for new obesity drugs
My dad, Randy, a 72-year-old retired sales manager, started to gain weight after grad school,…
STAT+: Medicare’s big experiment to fix kidney failure care hasn’t worked so far, studies say
A few years ago, the Centers for Medicare and Medicaid Services launched a big experiment….
Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Medicare’s Part D policy is blocking progress needed to achieve Black health equity
A new and effective class of anti-obesity medicines, along with lifestyle interventions and sometimes bariatric…
House panel passes bills to expand Medicare obesity drug coverage, cancer screening
WASHINGTON — A House committee overwhelmingly passed four bills on Thursday that would expand Medicare…
Exclusive: European VC Forbion hires Dyne CEO, expands into US
Want to stay on top of the science and politics driving biotech today? Sign up to get…